EC backs biosimilars

O'Driscoll, Catherine
May 2006
ICIS Chemical Business;5/1/2006, Vol. 1 Issue 17, p38
Trade Publication
The article reports on the marketing authorization granted by the European Commission for the biopharmaceutical drug Omnitrope as of May 2006. The European Commission has given its backing for the first generic version of a biopharmaceutical drug to be commercialized in the European Union. Omnitrope is used in treating growth hormone deficiency and is the first biogenetic drug to be granted marketing authorization in the European Union.


Related Articles

  • Growth hormone therapy market favours biobetters over biosimilars.  // Express Pharma;3/16/2015, p2 

    The article reports on the increased in the market of growth hormone (GH) drugs biobetters for the treatment of growth hormone deficiency (GHD) over the GH biosimilars in India. It provides the insights of analyst Lakshmi Dharmarajan of consulting firm GlobalData on the clinical advantages and...

  • Growth hormone use in children with short stature. Sadovsky, Richard // American Family Physician;2/1/1997, Vol. 55 Issue 2, p645 

    Presents a summary of the article titled `Growth of short children during and after discontinuation of growth hormone therapy,' by Z. Zadik, et al, from the 1996 issue, volume 81, of the `Journal of Clinical Endocrinology and Metabolism.'

  • Controversy about Treatment of Growth Hormone-Deficient Adults: A Commentary. Frohman, Lawrence A. // Annals of Internal Medicine;8/6/2002, Vol. 137 Issue 3, p202 

    Editorial. Comments on the controversy about the treatment of growth hormone deficiency in adults. Complexity of the diagnosis and therapy of patients with growth hormone deficiency; Degrees of growth hormone deficiency.

  • A new task for human growth hormone? Preece, M.A. // British Medical Journal (Clinical Research Edition);10/31/1981, Vol. 283 Issue 6300, p1145 

    Examines the role of human growth hormone on the treatment of children with growth hormone deficiency in Great Britain. Availability of the human growth hormone for treatment; Criteria of treatment for human growth hormone; Assessment on the supply and demand of the treatment.

  • The European Commission as a network organization. Metcalfe, Les // Publius: The Journal of Federalism;Fall96, Vol. 26 Issue 4, p43 

    Focuses on the reinvention of European Commission's role (EC) as a network organization in the European Union. Commitment of the 1992 Maastricht Treaty on European Union; Reasons for redefining EC's role; Structure and functions of EC; Sources of the management deficit; Core competence of EC.

  • EUROPEAN COMMISSION ISSUES SPRING REPORT ON MACEDONIA.  // Macedonian Diplomatic Bulletin;Apr2013, Issue 72, p10 

    The article offers information on the a spring report released by European Commission that shows the Republic of Macedonia has continued to follow all rules that define whether a country is eligible to join the European Union called "Copenhagen Criteria," for opening membership negotiations.

  • Increased pressure on Ireland to enforce group housing of sows.  // Irish Farmers Monthly;Mar2013, p10 

    The article informs that Ireland has received a formal notice from the European Commission to address deficiencies regarding the implementation of the European Union's legislation related to the group housing of sows.

  • EU ministers temper Framework reforms. Schiermeier, Quirin // Nature;12/20/2001-12/27/2001, Vol. 414 Issue 6866, p833 

    Focuses on the agreement between European Commission and European Union research ministers regarding the Framework program. Use of funds to integrate European research activities; Evaluation of networks independently; Support of parliament on computing projects.

  • Resolution Fund Tax Proposed for EU.  // American Banker;5/27/2010, Vol. 175 Issue 82, p16 

    The article discusses a proposal from the European Commission that European Union banks be charged a special tax, with proceeds dedicated to winding down the operations of failed banks in an orderly manner.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics